Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Wearable Electronic Breath Sound Sensing Device

NCT: NCT06734793 · RECRUITING

NCT IDNCT06734793
StatusRECRUITING
Start Date2025-02-26
Completion2026-12-31

Brief Summary

This study will assess the ability of a wearable stethoscope to monitor wheezing in high-risk asthma patients admitted at Children's Healthcare of Atlanta. This study is important to assist in the health management of patients with chronic lung diseases that can experience exacerbations leading to their health worsening and requiring hospitalization. The population that will be approached for this study will include 10 pediatric subjects hospitalized at Children's Healthcare of Atlanta for an asthma-related exacerbation. Participants will wear the patches for up to 8 hours on their chest and back wall from their date of consent until their hospital discharge. This may range from the participant taking part in 1 to 14 visits that could last up to 8 hours.

Frequently Asked Questions

What is Wearable Electronic Breath Sound Sensing Device?

Wearable Electronic Breath Sound Sensing Device is a clinical trial registered under NCT06734793. Current status: RECRUITING.

What is the status of NCT06734793?

The current status of NCT06734793 (Wearable Electronic Breath Sound Sensing Device) is: RECRUITING.

When did Wearable Electronic Breath Sound Sensing Device start?

Wearable Electronic Breath Sound Sensing Device started on 2025-02-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.